← Open Payments lookup

KIMBERLY KUREY: Open Payments

NPI 1326351032 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,801 in 96 payments from 14 companies in 2025. Trend: 2023 $2,503 · 2024 $1,630 · 2025 $1,801

Food & beverage: $1,801
CompanyPaymentsAmount
Collegium Pharmaceutical, Inc.25$389
Axsome Therapeutics, Inc.13$378
Salix Pharmaceuticals, a division of Bausch Health US, LLC24$303
ABBVIE INC.11$248
Otsuka America Pharmaceutical, Inc.5$117
Vanda Pharmaceuticals Inc.4$80
Janssen Pharmaceuticals, Inc3$72
Astellas Pharma US Inc3$70
Tonix Medicines, Inc.2$39
ANI Pharmaceuticals, Inc.2$37

Products named: XTAMPZA, Auvelity, RELISTOR, REXULTI, VRAYLAR, FANAPT, SPRAVATO, Veozah.

Industry payments across CT — which companies pay providers there.